Bio-Rad Laboratories Class A
BIO
346 hedge funds and large institutions have $5.94B invested in Bio-Rad Laboratories Class A in 2019 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 132 increasing their positions, 109 reducing their positions, and 43 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
42% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 43
34% more capital invested
Capital invested by funds: $4.43B → $5.94B (+$1.51B)
21% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 109
5% more funds holding
Funds holding: 328 → 346 (+18)
1.26% more ownership
Funds ownership: 76.95% → 78.22% (+1.3%)
5% less call options, than puts
Call options by funds: $66.9M | Put options by funds: $70.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$34M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$30.2M |
| 3 |
HCM
Hoplite Capital Management
New York
|
+$28.9M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$27.2M |
| 5 |
N
Natixis
Paris,
France
|
+$25.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$142M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$132M |
| 3 |
D.E. Shaw & Co
New York
|
-$36.1M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$31.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28.5M |
BIO Hedge Fund Activity: Q1 2019 in Review
346 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2019, worth a combined $5.94B — up 34% from $4.43B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new BIO positions and 43 closed out — a net gain of 18 holders — while 132 added to existing stakes and 109 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $34M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $142M sold.
- 346 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2019, up from 328 in Q4 2018.
- Funds reported $5.94B of Bio-Rad Laboratories Class A stock for Q1 2019, up 34% quarter-over-quarter.
- 61 funds opened new Bio-Rad Laboratories Class A positions in Q1 2019 and 43 closed out, a net change of +18 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2019 was AllianceBernstein, an estimated $34M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2019 was TimesSquare Capital Management, an estimated $142M sold.
Based on aggregated 13F filings for Q1 2019.